ABA Autism denied for failing step therapy by Humana?

Humana's specific coverage criteria for aba autism are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Humana Step-Therapy Denials for ABA: What They Mean and How to Appeal

Applied Behavior Analysis (ABA) is an established, evidence-based treatment for Autism Spectrum Disorder (ASD). A step-therapy denial from Humana means the plan is requiring that one or more other interventions be tried and documented as having failed before ABA will be authorized. For a developmental condition like ASD, this type of requirement is both clinically problematic and legally vulnerable.

### Why This Denial Happens

Humana's prior authorization policies for ABA sometimes contain language requiring documentation that "less intensive" behavioral or educational interventions have been attempted first. When a prescribing provider requests ABA directly without that documentation, the plan may deny it as a step-therapy failure — meaning the required prior step has not been satisfied.

### Why It Is Appealable

Step-therapy requirements applied to ABA for ASD face two distinct legal challenges:

Mental Health Parity (MHPAEA): If Humana does not impose equivalent step-therapy requirements on analogous medical/surgical benefits, the requirement violates federal parity law. Request Humana's non-quantitative treatment limitation (NQTL) analysis to evaluate this.

Clinical individualization: Clinical guidelines from organizations such as the American Academy of Pediatrics (AAP) and the relevant behavioral health specialty societies support individualized, intensity-appropriate ABA as a primary intervention — not a last resort. A step-therapy requirement that contradicts individualized clinical judgment may be overturned as inconsistent with generally accepted standards of care.

Your ACA Section 2719 external review rights and ERISA Section 503 full-and-fair review rights apply. The external review window is approximately four months from the denial date. Expedited review is available if delay would harm the child's health.

### The Appeal Process

1. Obtain the full denial rationale — Humana must state the specific step(s) required. Request the complete clinical criteria in writing. 2. Level 1 internal appeal — file within 180 days of denial. Humana must decide within 30 days (standard) or 72 hours (expedited). 3. Level 2 internal appeal if Level 1 is denied. 4. Independent external review through an IRO once internal remedies are exhausted. 5. Request expedited processing in writing if the child's current behavioral or developmental needs cannot tolerate delay.

### Documentation to Gather

• Diagnosis confirmation — formal ASD diagnosis with date, evaluator credentials, and instrument used.
• Prior intervention history — dates, providers, and documented outcomes of any behavioral, educational, or therapeutic interventions already tried.
• Clinical rationale for ABA specifically — treating BCBA and physician letter explaining why ABA is the appropriate level of care for this child's individualized presentation, and why any required prior steps are clinically inappropriate, already completed, or contraindicated for this child.
• Current functional assessment — BCBA assessment documenting current skill deficits and goals.
• Parity request — formal written request for Humana's NQTL analysis comparing step-therapy requirements across mental health and medical/surgical benefits.

### Criteria-Mapping Structure

Obtain Humana's published ABA step-therapy policy. Build a response table:

| Step Required by Policy | Documentation That Step Is Met or Inapplicable | |---|---| | Prior intervention X attempted | [Provider name, dates, outcome notes] | | Prior intervention X documented as failed | [Clinical notes with outcome data] | | Current ASD diagnosis confirmed | [Diagnostic report] | | ABA medically necessary per individualized assessment | [BCBA letter + treatment plan] |

Address each required step explicitly. If a step is clinically inapplicable to this child, the medical-necessity letter should explain why, citing the child's specific presentation.